Barclays’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
371,770
+47,875
| +15% | +$1.36M | ﹤0.01% | 1125 |
|
|
2025
Q1 | $9.56M | Buy |
323,895
+73,884
| +30% | +$2.18M | ﹤0.01% | 1044 |
|
|
2024
Q4 | $7.27M | Sell |
250,011
-5,688
| -2% | -$165K | ﹤0.01% | 1327 |
|
|
2024
Q3 | $11.7M | Buy |
255,699
+163,905
| +179% | +$7.53M | ﹤0.01% | 960 |
|
|
2024
Q2 | $3.75M | Sell |
91,794
-32,152
| -26% | -$1.31M | ﹤0.01% | 1322 |
|
|
2024
Q1 | $3.16M | Sell |
123,946
-74,168
| -37% | -$1.89M | ﹤0.01% | 1623 |
|
|
2023
Q4 | $1.79M | Buy |
198,114
+8,794
| +5% | +$79.5K | ﹤0.01% | 2226 |
|
|
2023
Q3 | $1.21M | Sell |
189,320
-314,350
| -62% | -$2M | ﹤0.01% | 1955 |
|
|
2023
Q2 | $5.59M | Buy |
503,670
+132,047
| +36% | +$1.46M | ﹤0.01% | 1171 |
|
|
2023
Q1 | $5.71M | Sell |
371,623
-4,857
| -1% | -$74.6K | ﹤0.01% | 1013 |
|
|
2022
Q4 | $8.36M | Buy |
376,480
+206,715
| +122% | +$4.59M | ﹤0.01% | 894 |
|
|
2022
Q3 | $2.77M | Buy |
169,765
+39,730
| +31% | +$649K | ﹤0.01% | 1434 |
|
|
2022
Q2 | $1.89M | Buy |
130,035
+78,709
| +153% | +$1.14M | ﹤0.01% | 1622 |
|
|
2022
Q1 | $947K | Buy |
+51,326
| New | +$947K | ﹤0.01% | 2364 |
|